Titlebook: Ventilator-Associated Pneumonia; Richard G. Wunderink (Director of Clinical Researc Book 2001 Springer Science+Business Media New York 200

FRONT

Irritate

Diagnosis of Pneumonia, secretions collected with protected specimen brush (PSB) or by bronchoalveolar lavage (BAL), without definitive consensus. However, recent studies focused on the outcome benefits of different diagnostic strategies may provide information that may change patient management and improve patient outcomes.

不能仁慈

Treatment of Ventilator-Associated Pneumonia,athogens (.). On the other hand, current data available indicate that the episodes caused by .,. or methicillin-resistant . (MRSA), cause an excess of mortality compared with the predictions made on the basis of severity-ofillness on ICU admission.(.–.)

搖晃

Mortality and Morbidity of Ventilator-Associated Pneumonia:,, Morbidity and mortality of nosocomial infections, in particular of ventilator-associated pneumonia (VAP), are considered to be very high in ICU patients (.,.,.,.,.). The excess in length ofstay and the extra costs are considerable (.,.,.). For all those reasons, nosocomial infections are considered a very significant public health problem.

defibrillator

COST

Diagnosis of Ventilator-Associated Pneumonia,biotic therapy, in the setting of suspected infection, should be guided by clinical criteria or by microbiologic data collected by quantitative sampling of lower airway secretions (.). This controversy exists because the clinical definition of pneumonia is quite sensitive, but not very specific, and

B-cell

600

TIGER

senile-dementia

Treatment of Ventilator-Associated Pneumonia,in our understanding of the pathogenesis of VAP and the operating characteristics of various diagnostic methods, the primary goal of this research into diagnosis - improved treatment and prevention strategies - remains in its infancy. Rather than the well-designed, critically reviewed studies now be